Literature DB >> 23392749

The potential of FDG-PET in the detection of occult lymph node metastasis: importance of patient selection and reference standard.

Remco de Bree, Otto S Hoekstra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23392749     DOI： 10.1007/s00405-013-2365-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN： 0937-4477            Impact factor:   2.503


× No keyword cloud information.
  10 in total

1.  The value of PET/CT to assess clinically negative necks.

Authors:  Enver Ozer; Barış Naiboğlu; Ryan Meacham; Cherie Ryoo; Amit Agrawal; David E Schuller
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-01-15       Impact factor: 2.503

2.  Use of integrated 18F-FDG PET/CT to improve the accuracy of initial cervical nodal evaluation in patients with head and neck squamous cell carcinoma.

Authors:  Han-Sin Jeong; Chung-Hwan Baek; Young-Ik Son; Man Ki Chung; Dong Kyung Lee; Joon Young Choi; Byung-Tae Kim; Hyung-Jin Kim
Journal:  Head Neck       Date:  2007-03       Impact factor: 3.147

3.  Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.

Authors:  Jong-Lyel Roh; Nam-Kyung Yeo; Jae Seung Kim; Jeong Hyun Lee; Kyung-Ja Cho; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  Oral Oncol       Date:  2007-01-04       Impact factor: 5.337

4.  Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging.

Authors:  R B J de Bondt; P J Nelemans; P A M Hofman; J W Casselman; B Kremer; J M A van Engelshoven; R G H Beets-Tan
Journal:  Eur J Radiol       Date:  2007-03-27       Impact factor: 3.528

5.  Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.

Authors:  Shu-Hang Ng; Tzu-Chen Yen; Joseph Tung-Chieh Chang; Sheng-Chieh Chan; Sheung-Fat Ko; Hung-Ming Wang; Li-Yu Lee; Chung-Jan Kang; Alex Mun-Ching Wong; Chun-Ta Liao
Journal:  J Clin Oncol       Date:  2006-09-20       Impact factor: 44.544

6.  FDG PET in oral and oropharyngeal cancer. Value for confirmation of N0 neck and detection of occult metastases.

Authors:  Christiaan A Krabbe; Pieter U Dijkstra; Jan Pruim; Bernard F M van der Laan; Jacqueline E van der Wal; Joost P Gravendeel; Jan L N Roodenburg
Journal:  Oral Oncol       Date:  2007-02-15       Impact factor: 5.337

7.  Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior?

Authors:  Jolijn Brouwer; Remco de Bree; Emile F I Comans; Jonas A Castelijns; Otto S Hoekstra; C René Leemans
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-12-17       Impact factor: 2.503

8.  FDG-PET in the clinically negative neck in oral squamous cell carcinoma.

Authors:  Bart M Wensing; Wouter V Vogel; Henri A M Marres; Matthias A W Merkx; Ernst J Postema; Wim J G Oyen; Frank J A van den Hoogen
Journal:  Laryngoscope       Date:  2006-05       Impact factor: 3.325

Review 9.  Immunohistochemical studies in the identification of lymph node micrometastases in patients with squamous cell carcinoma of the head and neck.

Authors:  Alessandra Rinaldo; Kenneth O Devaney; Alfio Ferlito
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2004       Impact factor: 1.538

10.  18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis.

Authors:  Panayiotis A Kyzas; Evangelos Evangelou; Despina Denaxa-Kyza; John P A Ioannidis
Journal:  J Natl Cancer Inst       Date:  2008-05-13       Impact factor: 13.506
  10 in total
  1 in total

1.  Sentinel lymph node detection in oral cancer: a within-patient comparison between [99mTc]Tc-tilmanocept and [99mTc]Tc-nanocolloid.

Authors:  Inne J den Toom; Rutger Mahieu; Rob van Rooij; Robert J J van Es; Monique G G Hobbelink; Gerard C Krijger; Bernard M Tijink; Bart de Keizer; Remco de Bree
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-08-25       Impact factor: 9.236
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.